logo

Acute Ischemic Stroke Diagnosis Market Size (2024 - 2029)

The market size for acute ischemic stroke diagnosis is projected to experience significant growth over the forecast period, driven by an increasing prevalence of stroke cases and a rising demand for diagnostic and surgical procedures. The impact of the COVID-19 pandemic initially disrupted medical procedures, but the market is recovering as technological advancements, an aging population, and a preference for minimally invasive procedures contribute to expansion. Despite challenges such as high medication use and surgical costs, the market is poised for growth due to increased healthcare spending and the accessibility of hospitals. However, stringent regulatory policies may pose constraints on market expansion.

Home Market Analysis Healthcare Research Medical Devices Research Acute Ischemic Stroke Diagnosis Industry Market Size

Market Size of Acute Ischemic Stroke Diagnosis Industry

Acute Ischemic Stroke Diagnosis Market Summary
Study Period 2019 - 2029
Market Size (2024) USD 2.20 Billion
Market Size (2029) USD 3.14 Billion
CAGR (2024 - 2029) 7.38 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Acute Ischemic Stroke Diagnosis Market Major Players

*Disclaimer: Major Players sorted in no particular order

Acute Ischemic Stroke Diagnosis Market Analysis

The Acute Ischemic Stroke Diagnosis Market size is estimated at USD 2.20 billion in 2024, and is expected to reach USD 3.14 billion by 2029, growing at a CAGR of 7.38% during the forecast period (2024-2029).

The acute ischemic stroke diagnostics market is anticipated to have been significantly impacted by the outbreak of the COVID-19 pandemic, as most of the medical procedures were deferred to contain the spread of SARS-Cov2 viral transmission. According to the research article published in the Journal of Cardiothoracic Surgery in March 2021 by Julie Sanders, cardiac surgery reduced by 50-75% during the pandemic, with a50% reduction in dedicated cardiac theater rooms and ICU beds in the United Kingdom. Additionally, as per the study results published in the journal of Annals of Thoracic Surgery, in July 2021, "The Effect of COVID-19 on Adult Cardiac Surgery in the United States in 717 103 Patients," an estimated 53% decrease in the total cardiac surgery volume was observed in the United States in 2020 as compared to 2019, which was majorly attributed to the impact of COVID-19 pandemic.

The rising prevalence of acute ischemic stroke cases is driving the global demand for both diagnostic and surgical procedures in acute stroke treatment. Cardiovascular diseases (CVDs) are the leading cause of death worldwide, according to World Health Organization (WHO) statistics for June 2021. It also states that an estimated 17.9 million people died from cardiovascular diseases in 2019, accounting for 32% of all global deaths. 85 % of these deaths were caused by a heart attack or a stroke. According to the same source, non-communicable diseases are responsible for 17 million premature deaths (under the age of 70) in 2019, with cardiovascular diseases accounting for 38% of these deaths.

Technological advancements in surgical procedures, a rising aging population, increased demand for minimally invasive procedures, and growth in health care spending are the other major factors driving the growth of the global acute ischemic stroke diagnosis and treatment market. As per the data reported by the American College of Cardiology, in November 2020, approximately 1.2 million angioplasties were performed in a year in the United States. Moreover, the high accessibility and affordability of hospitals, as compared to the specialty clinics, are expected to attract a large patient population.

Excessive usage of medication for the treatment of ischemic stroke and the high cost of surgical procedures are hindering the growth of the market. However, stringent regulatory policies are expected to restrict the market growth.

Acute Ischemic Stroke Diagnosis Industry Segmentation

As per the scope of the report, stroke occurs when blood flow to a part of the brain is interrupted as a result of a broken or blocked blood vessel. An ischemic stroke occurs when a blood vessel carrying blood to the brain is blocked or restricted by severely narrowed arteries or blood clots. The acute ischemic diagnosis included equipment/services that are involved in the diagnosis of acute ischemic stroke. The acute ischemic stroke diagnosis market is segmented by diagnostics type (computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and other diagnostics) and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Diagnostic Type
Computed Tomography
Magnetic Resonance Imaging
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Other Diagnostic Types
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Acute Ischemic Stroke Diagnosis Market Size Summary

The acute ischemic stroke diagnosis market is poised for significant growth, driven by the increasing prevalence of cardiovascular diseases and the rising demand for advanced diagnostic and surgical procedures. The market has been recovering from the disruptions caused by the COVID-19 pandemic, which had led to a substantial reduction in medical procedures globally. Technological advancements in imaging and surgical techniques, along with a growing aging population and increased healthcare spending, are key factors propelling the market forward. The widespread use of computed tomography (CT) scans, due to their rapid acquisition and accessibility, underscores the importance of imaging studies in diagnosing acute ischemic strokes. New product launches and regulatory approvals, such as Philips Healthcare's Spectral CT 7500, are expected to further enhance market growth.

North America currently dominates the acute ischemic stroke diagnosis market, supported by favorable government initiatives, technological innovations, and a high demand for ischemic stroke products. The region's market growth is bolstered by the increasing prevalence of cardiovascular diseases and strokes, prompting key players to adopt strategies like acquisitions and product launches to expand their presence. Companies such as Fujifilm Holdings Corporation, Samsung Electronics Co. Ltd, and Koninklijke Philips NV are actively expanding their operations in Asian markets, recognizing the potential for growth in countries like India, China, Japan, and South Korea. The introduction of advanced devices and technologies, such as CERENOVUS's EMBOGUARD and Phenox's pRESET 6-50, highlights the ongoing innovation in the field, promising to drive the market to new heights over the forecast period.

Explore More

Acute Ischemic Stroke Diagnosis Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 The Rising Number of Acute Stroke Patients

      2. 1.2.2 Technological Innovations in Diagnostic and Surgical Devices

    3. 1.3 Market Restraints

      1. 1.3.1 Alternative Treatments and High Costs

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 Diagnostic Type

      1. 2.1.1 Computed Tomography

      2. 2.1.2 Magnetic Resonance Imaging

      3. 2.1.3 Carotid Ultrasound

      4. 2.1.4 Cerebral Angiography

      5. 2.1.5 Electrocardiography

      6. 2.1.6 Echocardiography

      7. 2.1.7 Other Diagnostic Types

    2. 2.2 Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States

        2. 2.2.1.2 Canada

        3. 2.2.1.3 Mexico

      2. 2.2.2 Europe

        1. 2.2.2.1 Germany

        2. 2.2.2.2 United Kingdom

        3. 2.2.2.3 France

        4. 2.2.2.4 Italy

        5. 2.2.2.5 Spain

        6. 2.2.2.6 Rest of Europe

      3. 2.2.3 Asia-Pacific

        1. 2.2.3.1 China

        2. 2.2.3.2 Japan

        3. 2.2.3.3 India

        4. 2.2.3.4 Australia

        5. 2.2.3.5 South Korea

        6. 2.2.3.6 Rest of Asia-Pacific

      4. 2.2.4 Middle-East and Africa

        1. 2.2.4.1 GCC

        2. 2.2.4.2 South Africa

        3. 2.2.4.3 Rest of Middle-East and Africa

      5. 2.2.5 South America

        1. 2.2.5.1 Brazil

        2. 2.2.5.2 Argentina

        3. 2.2.5.3 Rest of South America

Acute Ischemic Stroke Diagnosis Market Size FAQs

The Acute Ischemic Stroke Diagnosis Market size is expected to reach USD 2.20 billion in 2024 and grow at a CAGR of 7.38% to reach USD 3.14 billion by 2029.

In 2024, the Acute Ischemic Stroke Diagnosis Market size is expected to reach USD 2.20 billion.

Acute Ischemic Stroke Diagnosis Market Report Snapshots

Acute Ischemic Stroke Diagnosis Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)